Concise, accurate diagnosis and treatment eveluation of osteoporosis patients using new imaging techniques

Concise, accurate diagnosis and treatment eveluation of osteoporosis patients using multiple new imaging techniques

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16009416

Enrollment

Unknown

Registered

2016-10-15

Start date

2016-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Control group:Oral take calcium tablet (=1000mg) and Vitamin D (=400IU) daily

Experimental group:Oral take Alendronate Sodium and Vitamin D3 Tablets (1 tablet / day, 70mg/2800IU per tablet)

Eligibility

Sex/Gender

Female

Age

55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women aged 50-70 years old; 2. DXA measurement lumbar BMD T value =2.5 SD, or =4.0 SD.

Exclusion criteria

Exclusion criteria: 1. Diseases which may affect bone metabolism, such as hyperthyroidism, Paget disease, renal osteodystrophy, etc; 2. A history of malignant tumor, radiation and chemotherapy, long-term use of hormone or calcium supplements; Oral phosphonic acid more than 36 months; 3. Major depression, schizophrenia and other mental illnesses or long-term use of antipsychotic drugs; 4. Serious single-shot lumbar compression fracture or multiple lumbar fractures; 5. Patients who can not do MRI scan due to various reasons such as age, history of metal stents in the body, or other factors.

Design outcomes

Primary

Measure	Time frame
Bone Mineral Density (BMD);Bone Mineral Density (BMD);Fat fraction;Parameters of blood perfusion;	—

Countries

China

Contacts

Public ContactGuangyu Tang

Shanghai tenth People's Hospital

tgy17@tongji.edu.cn+86 021-66306242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026